Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2934)
All Articles published online
|
Mar 28, 2009 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dai N, Lu AP, Shou CC, Li JY. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. World J Gastroenterol 2009; 15(12): 1499-1505 [PMID: 19322925 DOI: 10.3748/wjg.15.1499] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i12/1499.htm |
| Number | Citing Articles |
| 1 |
M. Wei, M. G. Haney, D. R. Rivas, J. S. Blackburn. Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo. Oncogenesis 2020; 9(1) doi: 10.1038/s41389-020-0192-5
|
| 2 |
Balint Csoboz, Imre Gombos, Eniko Tatrai, Jozsef Tovari, Anna L. Kiss, Ibolya Horvath, Laszlo Vigh. Chemotherapy induced PRL3 expression promotes cancer growth via plasma membrane remodeling and specific alterations of caveolae-associated signaling. Cell Communication and Signaling 2018; 16(1) doi: 10.1186/s12964-018-0264-8
|
| 3 |
Jianbo Xiong, Zhengrong Li, Yang Zhang, Daojiang Li, Guoyang Zhang, Xianshi Luo, Zhigang Jie, Yi Liu, Yi Cao, Zhibiao Le, Shengxing Tan, Wenyu Zou, Peitao Gong, Lingyu Qiu, Yuanyuan Li, Huan Wang, Heping Chen. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Oncology Reports 2016; 36(4): 1819 doi: 10.3892/or.2016.5030
|
| 4 |
Min Thura, Abdul Qader Omer Al-Aidaroos, Wei Peng Yong, Koji Kono, Abhishek Gupta, You Bin Lin, Kousaku Mimura, Jean Paul Thiery, Boon Cher Goh, Patrick Tan, Ross Soo, Cheng William Hong, Lingzhi Wang, Suling Joyce Lin, Elya Chen, Sun Young Rha, Hyun Cheol Chung, Jie Li, Sayantani Nandi, Hiu Fung Yuen, Shu-Dong Zhang, Yeoh Khay Guan, Jimmy So, Qi Zeng. PRL3-zumab, a first-in-class humanized antibody for cancer therapy. JCI Insight 2016; 1(9) doi: 10.1172/jci.insight.87607
|
| 5 |
Qian Song, Yutian Zheng, Junzhou Wu, Sheng Wang, Lin Meng, Qian Yao, Zhongwu Li, Shenyi Lian. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.717688
|
| 6 |
Amanda M Campbell, Zhong-Yin Zhang. Phosphatase of regenerating liver: a novel target for cancer therapy. Expert Opinion on Therapeutic Targets 2014; 18(5): 555 doi: 10.1517/14728222.2014.892926
|
| 7 |
Min Wei, Konstantin V. Korotkov, Jessica S. Blackburn. Targeting phosphatases of regenerating liver (PRLs) in cancer. Pharmacology & Therapeutics 2018; 190: 128 doi: 10.1016/j.pharmthera.2018.05.014
|
| 8 |
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
|
| 9 |
ZHEN-HUA SUN, PING BU. Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line. Experimental and Therapeutic Medicine 2012; 3(6): 1077 doi: 10.3892/etm.2012.516
|
| 10 |
Yuqiong Liu, Xi Lou, Ke Guo, Jun-Yi Lei, Huixiang Li. Expression of Phosphatase Regenerating Liver-1 in Esophageal Squamous Cell Carcinoma Associated with Metastasis. ISRN Pathology 2011; 2011: 1 doi: 10.5402/2011/680890
|
| 11 |
Abudureheman Mayinuer, Mahmut Yasen, Kaoru Mogushi, Gulanbar Obulhasim, Maimaiti Xieraili, Arihiro Aihara, Shinji Tanaka, Hiroshi Mizushima, Hiroshi Tanaka, Shigeki Arii. Upregulation of Protein Tyrosine Phosphatase Type IVA Member 3 (PTP4A3/PRL-3) is Associated with Tumor Differentiation and a Poor Prognosis in Human Hepatocellular Carcinoma. Annals of Surgical Oncology 2013; 20(1): 305 doi: 10.1245/s10434-012-2395-2
|
| 12 |
Liren Hu, Haiqing Luo, Wenjuan Wang, Hongjiao Li, Taiping He, Rakesh K. Srivastava. Poor Prognosis of Phosphatase of Regenerating Liver 3 Expression in Gastric Cancer: A Meta-Analysis. PLoS ONE 2013; 8(10): e76927 doi: 10.1371/journal.pone.0076927
|
| 13 |
Isabel Radke, Martin Götte, Martin Smollich, Ninette Scharle, Ludwig Kiesel, Pia Wülfing. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro. Archives of Gynecology and Obstetrics 2017; 296(6): 1153 doi: 10.1007/s00404-017-4542-2
|
| 14 |
Bala Basak Oven Ustaalioglu, Ahmet Bilici, Nagehan Ozdemir Barisik, Mehmet Aliustaoglu, Fugen Aker Vardar, Burcak Erkol Yilmaz, Mesut Seker, Mahmut Gumus. Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer. Clinical and Translational Oncology 2012; 14(12): 911 doi: 10.1007/s12094-012-0880-5
|
| 15 |
Caroline N. Smith, Kyle Kihn, Zachary A. Williamson, K. Martin Chow, Louis B. Hersh, Konstantin V. Korotkov, Daniel Deredge, Jessica S. Blackburn, Arunava Roy. Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3. PLOS ONE 2023; 18(5): e0285964 doi: 10.1371/journal.pone.0285964
|
| 16 |
K Guzińska-Ustymowicz, J Kiśluk, SJ Terlikowski, A Pryczynicz, K Niewiarowska, M Ustymowicz, M Hawryluk, M Południewski, A Kemona. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases. Advances in Medical Sciences 2013; 58(2): 221 doi: 10.2478/v10039-012-0079-6
|
| 17 |
J Stebbing, L C Lit, H Zhang, R S Darrington, O Melaiu, B Rudraraju, G Giamas. The regulatory roles of phosphatases in cancer. Oncogene 2014; 33(8): 939 doi: 10.1038/onc.2013.80
|
| 18 |
Keishi Yamashita, Shinichi Sakuramoto, Masahiko Watanabe. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surgery Today 2011; 41(1): 24 doi: 10.1007/s00595-010-4370-5
|
| 19 |
Ahmet Bilici, Bala Basak Oven Ustaalioglu, Dilek Yavuzer, Mesut Seker, Alpaslan Mayadagli, Mahmut Gumus. Prognostic Significance of High Phosphatase of Regenerating Liver-3 Expression in Patients with Gastric Cancer Who Underwent Curative Gastrectomy. Digestive Diseases and Sciences 2012; 57(6): 1568 doi: 10.1007/s10620-012-2076-9
|
| 20 |
YI CAO, YI TU, JINHONG MEI, ZHENGRONG LI, ZHIGANG JIE, SHAN XU, LINLIN XU, SHANSHAN WANG, YIFENG XIONG. RNAi-mediated knockdown of PRL-3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC-7901. Molecular Medicine Reports 2013; 7(6): 1805 doi: 10.3892/mmr.2013.1420
|
| 21 |
Cheng Xing, Xing-Xing Lu, Peng-Da Guo, Tong Shen, Shen Zhang, Xiao-Shun He, Wen-Juan Gan, Xiu-Ming Li, Jing-Ru Wang, Yuan-Yuan Zhao, Hua Wu, Jian-Ming Li. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis. Cancer Research 2016; 76(1): 83 doi: 10.1158/0008-5472.CAN-14-3595
|
| 22 |
Mingyang Yu, Chunxu Lin, Min Wei. A pan-cancer analysis of oncogenic protein tyrosine phosphatase subfamily PTP4As. Journal of Holistic Integrative Pharmacy 2023; 4(2): 185 doi: 10.1016/j.jhip.2023.07.001
|
| 23 |
H Yin, X Huang, M Tao, Q Hu, J Qiu, W Chen, J Wu, Y Xie. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial–mesenchymal transition. Cancer Gene Therapy 2017; 24(4): 180 doi: 10.1038/cgt.2017.3
|
| 24 |
Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Helena Bertilsson, Roy Bremnes, Magne Børset, Lill-Tove Busund, Tobias Slørdahl, Aamir Ahmad. Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer. PLOS ONE 2017; 12(11): e0189000 doi: 10.1371/journal.pone.0189000
|
| 25 |
Krystle T. Pagarigan, Bryce W. Bunn, Jake Goodchild, Travis K. Rahe, Julie F. Weis, Leslie J. Saucedo, Madhuri Kango-Singh. Drosophila PRL-1 Is a Growth Inhibitor That Counteracts the Function of the Src Oncogene. PLoS ONE 2013; 8(4): e61084 doi: 10.1371/journal.pone.0061084
|
| 26 |
Sofi G. Julien, Nadia Dubé, Serge Hardy, Michel L. Tremblay. Inside the human cancer tyrosine phosphatome. Nature Reviews Cancer 2011; 11(1): 35 doi: 10.1038/nrc2980
|
| 27 |
Sweksha Lohani, Yosuke Funato, Yuki Akieda, Kiyohito Mizutani, Yoshimi Takai, Tohru Ishitani, Hiroaki Miki. A novel role for PRL in regulating epithelial cell density by inducing apoptosis at confluence. Journal of Cell Science 2022; 135(2) doi: 10.1242/jcs.258550
|
| 28 |
Lina Wang, Ting Yu, Wei Li, Mengmeng Li, Qianfei Zuo, Quanming Zou, Bin Xiao. The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3. Oncogene 2019; 38(17): 3134 doi: 10.1038/s41388-018-0642-0
|
| 29 |
Dylan R. Rivas, Mark Vincent C. Dela Cerna, Caroline N. Smith, Shilpa Sampathi, Blaine G. Patty, Donghan Lee, Jessica S. Blackburn. A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3). Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89668-5
|